Unique ID issued by UMIN | UMIN000022638 |
---|---|
Receipt number | R000026086 |
Scientific Title | A safety study of skin care products containing Bioceramide in atopic dermatitis patients |
Date of disclosure of the study information | 2016/06/08 |
Last modified on | 2016/10/05 12:58:03 |
A safety study of skin care products containing Bioceramide in atopic dermatitis patients
A safety study of skin care products containing Bioceramide in atopic dermatitis patients
A safety study of skin care products containing Bioceramide in atopic dermatitis patients
A safety study of skin care products containing Bioceramide in atopic dermatitis patients
Japan |
atopic dermatitis
Dermatology |
Others
NO
To evaluate the safety of skin care products containing Bioceramide
Safety
Exploratory
Pragmatic
Not applicable
To evaluate the safety of skin care products containing Bioceramide based upon 1) frequency, types and severity of adverse events, and 2) results of safety assessments by dermatologists
To evaluate the efficacy of skin care products containing Bioceramide based upon dermatological assessments, itch score, skin hydration and improvement grade of symptom
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Other |
Skin care products containing Bioceramide (cleanser, skin toner and moisturizing gel) are applied twice a day for 28 days
20 | years-old | <= |
54 | years-old | >= |
Male and Female
Atopic dermatitis patients;
1)with slight severity condition,
2)who are no need for treatment by steroidal and immunosuppressant drugs,
3)who are Japanese females and males between 20 years to 54 years old, and
4)who understand in detail and have written consent for the study protocol.
1)Patients with an evidence of skin inflammation caused by atopic dermatitis or with the other skin disease that would interfere with clinical evaluation
2)Patients with any known allergies and hypersensitivity to any of the ingredients of the test products
3)Patients with underlying disease who need a admission to a hospital
4)Patients taking steroidal or immunosuppressant drugs for atopic dermatitis
5)Patients with history of participation in another clinical study within six (6) months
6)Women who are pregnant or breastfeeding, and women of reproductive potential who are not willing to use adequate contraception during study
7)Patients who are not willing to observe the limitation or prohibit matters
8)Patients who are judged inappropriate to participate by investigators.
35
1st name | |
Middle name | |
Last name | Masatoshi Ito |
Japan Aesthetic Dermatology Symposium
President
15-1-604,Himonya 5-Chome,Meguro-ku,Tokyo,Japan
03-3794-1235
m.tanaka@jp-ads.com
1st name | |
Middle name | |
Last name | Mikiko Tanaka |
Japan Aesthetic Dermatology Symposium
Secretariat
2-3-5,Minatomirai,Nishi-ku,Yokohama-shi,Kanagawa,Japan
045-682-4114
m.tanaka@jp-ads.com
Zenyaku Kogyo Co., LTD,
Zenyaku Kogyo Co., LTD,
Profit organization
NO
クイーンズスクエア 皮膚科・アレルギー科
(Queen's Square Medical Facilities)
2016 | Year | 06 | Month | 08 | Day |
Unpublished
Completed
2016 | Year | 04 | Month | 15 | Day |
2016 | Year | 06 | Month | 08 | Day |
2016 | Year | 06 | Month | 07 | Day |
2016 | Year | 10 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026086
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |